- Home
- A-Z Publications
- Current Medicinal Chemistry - Central Nervous System Agents
- Previous Issues
- Volume 5, Issue 2, 2005
Current Medicinal Chemistry - Central Nervous System Agents - Volume 5, Issue 2, 2005

Volume 5, Issue 2, 2005
-
-
Inhibition of Monoamine Neurotransmitter Transporters and Central Nervous System Stimulation Induced by Synthetic Local Anesthetics and Cocaine: A Comparative Review-Update
Authors: Toshihiro Dohi, Shigeo Kitayama and Katsuya MoritaMonoamine transporters (MAT) are the target molecules of cocaine for induction of its central stimulating effect, resultant reward. Sensitization of central nervous system stimulation by cocaine is produced by intermittent use of cocaine and typically appears in behavioral hyperactivity in animals. Na+ channels are other important molecules for induction of seizures of cocaine in abuse. The mechanisms for the expression Read More
-
-
-
Inhibitors of Cyclin-Dependent Kinases: Potential Drugs for the Treatment of Neurodegenerative Disorders?
The pharmacological treatment of neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (ALS) currently represents a major medical challenge. The mechanisms involved in the apoptotic neuronal cell death, associated with such disorders, are still not clear, but recent data suggest that cyclindependent kinases (CDKs) play a prominent role (Liu et al., 2003). Canoni Read More
-
-
-
Alzheimer's Disease and Non-Steroidal Anti-Inflammatory Drugs: Old Therapeutic Tools with Novel Mechanisms of Action?
More LessAlzheimer's disease (AD) is the most common form of neurodegenerative disease with dementia in the elderly. Besides the pathological hallmarks of the disease, which include cerebral deposits of amyloid-β (Aβ) peptides and neurofibrillary tangles, AD brain exhibits clear evidence of a chronic inflammatory process. Epidemiological studies have shown that long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) reduces Read More
-
-
-
Transcriptional Dysregulation: A Therapeutic Target for Polyglutamine Diseases
Authors: Jonathan Cornett, Meyer Friedman, Shi-Hua Li and Xiao-Jiang LiAt least nine neurodegenerative diseases are caused by the expansion of a polyglutamine (polyQ) tract in the associated disease proteins. Although these proteins are normally expressed in either the cytoplasm or the nucleus, polyQ expansion can cause them to accumulate and aggregate in the nucleus. Moreover, addition of an expanded polyQ tract to a small cytoplasmic protein, hypoxanthine-guanine-phosphoribosyltransferas Read More
-
-
-
Mechanisms of Neuropathic Pain
Authors: Tony L. Yaksh and Linda S. SorkinInjury to the peripheral nerve can lead to paradoxical changes in functioning such that there is an ongoing dysesthesia and an altered processing such that low threshold stimuli are responded to in humans and animals as if they were painful. What are the mechanisms underlying these anomalous behaviors? The biological changes induced by nerve injury are complex. To attribute functional relevance to the many chang Read More
-
-
-
Current Progress in Molecular Responses to Acidosis in the Central Nervous System
Authors: Noriaki Shimokawa and Noriyuki KoibuchiThe ventral medullary surface of the medulla oblongata is known as the site of the central chemosensitive neurons in humans. These neurons sense decrease in pH of the cerebrospinal fluid followed by hypercapnia (increased arterial CO2) and induce hyperventilation. Recently, several advances have been made in understanding central chemosensitivity at the molecular and cellular levels. Recent studies have identified Read More
-
-
-
CD14-Dependent Innate Immunity-Mediated Neuronal Damage in Vivo is Suppressed by NSAIDs and Ablation of a Prostaglandin E2 Receptor, EP2
Authors: D. Milatovic, S. Zaja-Milatovic, K. S. Montine, M. Nivison and T. J. MontineActivated innate immune response in brain has been extensively associated with several diseases, including Alzheimer's disease, HIV-associated dementia, ischemia, head trauma, stroke, cerebral palsy, axonal degeneration in multiple sclerosis, and autism. Although initially investigated because of its role innate immune response to microorganisms, the CD14/Toll-like receptor pathway is now appreciated as a critical ele Read More
-
-
-
Neuroactive Steroids as Targets for Development of Novel Pain Therapies
More LessIt is well established that the neuroactive steroids can modulate neuronal activity in the peripheral and central nervous system causing a variety of behavioral and neuroendocrine changes in humans and animals. It is largely believed that their effects on neurosensory processing and neuronal excitability are primarily mediated by effects on various ligandgated ion channels, with much attention focused on the modulation of γ-a Read More
-
Volumes & issues
Most Read This Month
Article
content/journals/cmccnsa
Journal
10
5
false
en
